Active Ingredient(s):Obiltoxaximab FDA Approved: * March 18, 2016 Pharm Company: *ELUSYS THERAPEUTICS INC Category:Antibiotics
Obiltoxaximab, sold under the brand name Anthim, is a monoclonal antibody medication designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax).
The medication was developed by Elusys Therapeutics, Inc.
1 Medical uses
2 Society and culture
2.1 Legal status
4 External links
Obiltoxaximab is indicated in combination wit...
* May have multiple approval dates, manufacturers, or labelers.